In 1995, a phase I pilot study (NCT00004386) was initiated, which used an Ad type 5 vector carrying human OTC cDNA administered into the right hepatic artery in adults with partial OTCD. This evidence concerns the gene OTC and ornithine carbamoyltransferase deficiency.